Profitability
Weight: 20%
D-
30
- 5yr Avg ROIC -11.6%
- Operating Margin Trend +586.77 pp/yr
AGIO
Agios Pharmaceuticals, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 3 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 30.0 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
A-
83
- 5yr Avg ROE 13.8%
- 5yr Share-Count CAGR -3.4%
Growth Quality
Weight: 15%
C+
60
- Revenue-Growth Years (5) 3/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -1271.5%
- 5yr FCF/NI Conversion -0.42x
Balance Sheet
Weight: 20%
C
55
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) 30.00x
- Altman Z-Score 10.12
Stability
Weight: 15%
C+
58
- Negative-Revenue Years (5) 0/5
- Piotroski F-Score 2
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.2 of 2 gurus held; 2 added.
- Holders
- 2
- Avg Δ position
- +1680.2%
- New buys
- 0
- Full exits
- 0